Literature DB >> 28827476

Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney.

Sanket N Patel1, Quaisar Ali1, Preethi Samuel1, Ulrike Muscha Steckelings1, Tahir Hussain2.   

Abstract

The actions of angiotensin II type 2 receptor (AT2R) and the receptor Mas (MasR) are complex but show similar pronatriuretic function; particularly, AT2R expression and natriuretic function are enhanced in obese/diabetic rat kidney. In light of some reports suggesting a potential positive interaction between these receptors, we tested hypothesis that renal AT2R and MasR physically interact and are interdependent to stimulate cell signaling and promote natriuresis in obese rats. We found that infusion of AT2R agonist C21 in obese Zucker rats (OZR) increased urine flow and urinary Na excretion which were attenuated by simultaneous infusion of the AT2R antagonist PD123319 or the MasR antagonist A-779. Similarly, infusion of MasR agonist Ang-(1-7) in OZR increased urine flow and urinary Na excretion, which were attenuated by simultaneous infusion of A-779 or PD123319. Experiment in isolated renal proximal tubules of OZR revealed that both the agonists C21 and Ang-(1-7) stimulated NO which was blocked by either of the receptor antagonists. Dual labeling of AT2R and MasR in OZR kidney sections and human proximal tubule epithelial cells showed that AT2R and MasR are colocalized. The AT2R also coimmunoprecipitated with MasR in cortical homogenate of OZR. Immunoblotting of cortical homogenate cross-linked with zero-length oxidative (sulfhydryl groups) cross-linker cupric-phenanthroline revealed a shift of AT2R and MasR bands upward with overlapping migration for their complexes which were sensitive to the reducing β-mercaptoethanol, suggesting involvement of -SH groups in cross-linking. Collectively, the study reveals that AT2R and MasR are colocalized and functionally interdependent in terms of stimulating NO and promoting diuretic/natriuretic response.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin-II type 2 receptor; co-immunoprecipitation; colocalization; natriuresis; obese Zucker rat; receptor Mas; renal epithelial cells

Mesh:

Substances:

Year:  2017        PMID: 28827476      PMCID: PMC5599348          DOI: 10.1161/HYPERTENSIONAHA.117.09679

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   9.897


  46 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.

Authors:  Tanya M Gwathmey; Brian M Westwood; Nancy T Pirro; Lijun Tang; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

3.  Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation.

Authors:  Shin-Ichiro Miura; Sadashiva S Karnik; Keijiro Saku
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

4.  Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.

Authors:  Quaisar Ali; Sanket Patel; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-08

5.  Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Authors:  Masaru Iwai; Rui Chen; Zhen Li; Tetsuya Shiuchi; Jun Suzuki; Ayumi Ide; Masahiro Tsuda; Midori Okumura; Li-Juan Min; Masaki Mogi; Masatsugu Horiuchi
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

6.  Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

Authors:  Pia E Walters; Tracey A Gaspari; Robert E Widdop
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

7.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

8.  Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

9.  Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.

Authors:  Concepcion Peiró; Susana Vallejo; Florian Gembardt; Verónica Azcutia; Silvia Heringer-Walther; Leocadio Rodríguez-Mañas; Heinz-Peter Schultheiss; Carlos F Sánchez-Ferrer; Thomas Walther
Journal:  J Hypertens       Date:  2007-12       Impact factor: 4.844

10.  Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.

Authors:  Panpan Hao; Jianmin Yang; Yanping Liu; Mingxiang Zhang; Kai Zhang; Fei Gao; Yuguo Chen; Cheng Zhang; Yun Zhang
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

View more
  16 in total

1.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 3.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

4.  Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells.

Authors:  Mehmet Hakan Ozdener; Sunila Mahavadi; Shobha Mummalaneni; Vijay Lyall
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

Review 5.  Dimerization of AT2 and Mas Receptors in Control of Blood Pressure.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 6.  Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Authors:  Naureen Fatima; Sanket N Patel; Tahir Hussain
Journal:  Hypertension       Date:  2021-04-12       Impact factor: 10.190

Review 7.  Revisiting the Brain Renin-Angiotensin System-Focus on Novel Therapies.

Authors:  Liwei Ren; Xifeng Lu; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

8.  Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice.

Authors:  Fei Xue; Jianmin Yang; Jing Cheng; Wenhai Sui; Cheng Cheng; Hongxuan Li; Meng Zhang; Jie Zhang; Xingli Xu; Jing Ma; Lin Lu; Jinfeng Xu; Meng Zhang; Yun Zhang; Cheng Zhang
Journal:  Br J Pharmacol       Date:  2020-03-02       Impact factor: 8.739

Review 9.  Within the Brain: The Renin Angiotensin System.

Authors:  LaDonya Jackson; Wael Eldahshan; Susan C Fagan; Adviye Ergul
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

10.  Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.

Authors:  Ye-Ping Ma; Yue Yang; Shi-Min Jiang; Lin Liu; Zheng Zhang; Yi-Ning Wang; Gu-Ming Zou; Wen-Ge Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.